“Neuroscience & Alzheimer's”

Filter

14 of 3,901

Sort

LLYELI LILLY & Co🔥

Healthcare · Pharmaceuticals

$1.01T-2.5%

P/E 49.0·P/S 15.5·Mgn 31.7%·ROE 77.8%·FCF —

F 8

RPRXRoyalty Pharma plc⚡

Healthcare · Pharmaceuticals

$24.32B-1.8%

P/E 17.9·P/S 10.0·Mgn 55.7%·ROE 7.9%·FCF —

—

13D

NBIXNEUROCRINE BIOSCIENCES INC

Healthcare · Biotechnology

$16.06B-0.9%

P/E 24.0·P/S 5.2·Mgn 21.6%·ROE 14.7%·FCF 4.7%

F 6

Red 8-K

RVTYREVVITY, INC.🔥

Healthcare · Diagnostics & Tools

$11.12B+0.0%

P/E 46.1·P/S 3.9·Mgn 8.4%·ROE 3.3%·FCF 4.6%

—

PRAXPraxis Precision Medicines, Inc.⚡

Healthcare · Pharmaceuticals

$7.43B-4.5%

P/E —·P/S —·Mgn —·ROE -34.5%·FCF -3.4%

—

BHVNBiohaven Ltd.⚡

Healthcare · Pharmaceuticals

$1.70B-0.5%

P/E —·P/S 2.0·Mgn -108.3%·ROE -1418.8%·FCF —

—

MPLTMapLight Therapeutics, Inc.

Healthcare · Pharmaceuticals

$1.26B+4.5%

P/E —·P/S —·Mgn —·ROE -35.2%·FCF —

—

Red 8-K

PRTAPROTHENA CORP PUBLIC LTD CO

Healthcare · Pharmaceuticals

$432M-1.8%

P/E —·P/S 7.5·Mgn -260.9%·ROE -87.0%·FCF —

—

ABOSAcumen Pharmaceuticals, Inc.

Healthcare · Biotechnology

$171M-3.6%

P/E —·P/S —·Mgn —·ROE -172.3%·FCF —

—

13DDilut.

NRXPNRX Pharmaceuticals, Inc.

Healthcare · Pharmaceuticals

$164M+2.3%

P/E —·P/S 134.2·Mgn -2336.5%·ROE —·FCF —

—

PMNProMIS Neurosciences Inc.

Healthcare · Pharmaceuticals

$93M+22.4%

P/E —·P/S —·Mgn —·ROE —·FCF —

—

Red 8-K

LONALeonaBio, Inc.

Healthcare · Biotechnology

$78M+3.7%

P/E —·P/S —·Mgn —·ROE —·FCF —

—

13D

ANVSAnnovis Bio, Inc.

Healthcare · Pharmaceuticals

$76M0.0%

P/E —·P/S —·Mgn —·ROE -171.2%·FCF —

—

FLNAFILANA THERAPEUTICS, INC.

Healthcare · Pharmaceuticals

$60M-2.5%

P/E 1.9·P/S 1.5·Mgn 76.7%·ROE 65.3%·FCF —

—

Red 8-K

Filings · filterAll 10-K 10-Q 8-K S-1 DEF 14A SC 13D

Filings

40 shown

NNDMNano Dimension Ltd.

SC 13D

Activist stake — an investor has acquired more than 5% with intent to influence.

Jun 30, 2026·1d ago

ALKTALKAMI TECHNOLOGY, INC.

SC 13D

Activist stake — an investor has acquired more than 5% with intent to influence.

Companies above the $50M market cap · $1 pricefloor; SPAC/shells hidden by default. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Filings current to Jun 30 · prices to Jun 30.